Leslie Tari
2021
In 2021, Leslie Tari earned a total compensation of $1M as Chief Scientific Officer at Cidara Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $124,100 |
|---|---|
| Option Awards | $208,656 |
| Salary | $359,050 |
| Stock Awards | $331,520 |
| Other | $2,900 |
| Total | $1,026,226 |
Tari received $359.1K in salary, accounting for 35% of the total pay in 2021.
Tari also received $124.1K in non-equity incentive plan, $208.7K in option awards, $331.5K in stock awards and $2.9K in other compensation.
Rankings
In 2021, Leslie Tari's compensation ranked 8,717th out of 12,415 executives tracked by ExecPay. In other words, Tari earned more than 29.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,717 out of 12,415 | 30th |
Division Manufacturing | 3,865 out of 5,505 | 30th |
Major group Chemicals And Allied Products | 1,708 out of 2,375 | 28th |
Industry group Drugs | 1,519 out of 2,096 | 28th |
Industry Biological Products, Except Diagnostic Substances | 331 out of 449 | 26th |
Source: SEC filing on April 29, 2022.
Tari's colleagues
We found two more compensation records of executives who worked with Leslie Tari at Cidara Therapeutics in 2021.